Type-I IFNs (e.g. IFN-α, IFN-β and IFN-ω) are also involved in cell differentiation and anti-tumour defence processes, and besides that, they are also able to sensitize tumour cells for chemo-and radiotherapy [9–10]. The gene discussed is IFNA2; the disease is neoplasm.